Timothy A. Springer, Director, 10% Owner at Tectonic Therapeutic, Inc. (TECX), bought 280,128 shares at $16.73 ($4.5M) on 2025-04-10, disclosed to the SEC on 2025-04-11.
Open-market purchase of $4.5M TECX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.62 | 2,861 | $42K | 0.9% |
| 2 | $14.62 | 16,215 | $237K | 5.2% |
| 3 | $14.62 | 16,215 | $237K | 5.2% |
| 4 | $15.23 | 857 | $13K | 0.3% |
| 5 | $15.23 | 4,856 | $74K | 1.6% |
| 6 | $15.23 | 4,856 |
| $74K |
| 1.6% |
| 7 | $16.73 | 8,092 | $135K | 3.0% |
| 8 | $16.73 | 8,092 | $135K | 3.0% |
| 9 | $16.73 | 45,858 | $767K | 16.9% |
| 10 | $16.73 | 45,858 | $767K | 16.9% |
| 11 | $16.31 | 9,478 | $155K | 3.4% |
| 12 | $16.31 | 9,478 | $155K | 3.4% |
| 13 | $16.31 | 53,706 | $876K | 19.3% |
| 14 | $16.31 | 53,706 | $876K | 19.3% |
| Total | $16.22 avg | 280,128 | $4.5M | 100% |
| Filing → |
| RNAC | BUY | 2025-03-20 | $2.7M | — | Filing → |
| TECX | BUY | 2025-02-07 | $47.0M | — | Filing → |
| RNAC | BUY | 2025-01-15 | $660K | — | Filing → |